Gara Jalqabaatti › Kansarii Epithelial Ovarii
Qorannoo klinikaalii Kansarii Epithelial Ovarii Ameerikaa Keessatti hirmaatuu
Qorannoo 26 Kansarii Epithelial Ovarii f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Durham, NCQorannoo 8
- Boston, MAQorannoo 8
- New York City, NYQorannoo 7
- San Diego, CAQorannoo 7
- Chicago, ILQorannoo 7
- Baltimore, MDQorannoo 6
- Philadelphia, PAQorannoo 6
- Cleveland, OHQorannoo 6
- Houston, TXQorannoo 6
- Minneapolis, MNQorannoo 5
- Salt Lake City, UTQorannoo 5
- Portland, ORQorannoo 5
- Edison, NJQorannoo 5
- Los Angeles, CAQorannoo 5
- Dallas, TXQorannoo 4
- Birmingham, ALQorannoo 4
- San Antonio, TXQorannoo 4
- St. Louis, MOQorannoo 4
- New Haven, CTQorannoo 4
- Arlington, VAQorannoo 4
- Seattle, WAQorannoo 4
- Queens, NYQorannoo 4
- Mountain View, CAQorannoo 3
- Shreveport, LAQorannoo 3
- Dayton, OHQorannoo 3
- Sioux Falls, SDQorannoo 3
- Nashville, TNQorannoo 3
- Billings, MTQorannoo 3
- Grand Rapids, MIQorannoo 3
- West Palm Beach, FLQorannoo 3
- Indianapolis, INQorannoo 3
- Rochester, MNQorannoo 3
- Aurora, COQorannoo 3
- New Orleans, LAQorannoo 3
- San Francisco, CAQorannoo 3
- Columbus, OHQorannoo 3
- Providence, RIQorannoo 3
- Tampa, FLQorannoo 3
- Oklahoma City, OKQorannoo 3
- Washington, DCQorannoo 3
Naannoon
- AlabamaQorannoo 4
- ArizonaQorannoo 4
- CaliforniaQorannoo 10
- ColoradoQorannoo 4
- ConnecticutQorannoo 4
- FloridaQorannoo 11
- GeorgiaQorannoo 3
- IllinoisQorannoo 8
- IndianaQorannoo 3
- LouisianaQorannoo 4
- MarylandQorannoo 7
- MassachusettsQorannoo 9
- MichiganQorannoo 5
- MinnesotaQorannoo 7
- MissouriQorannoo 5
- MontanaQorannoo 3
- New JerseyQorannoo 9
- New YorkQorannoo 10
- North CarolinaQorannoo 9
- OhioQorannoo 10
- OklahomaQorannoo 3
- OregonQorannoo 6
- PennsylvaniaQorannoo 10
- Rhode IslandQorannoo 3
- South DakotaQorannoo 3
- TennesseeQorannoo 6
- TexasQorannoo 12
- UtahQorannoo 5
- VirginiaQorannoo 6
- WashingtonQorannoo 6
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dubartoota · Haaromfame 05-Onk-2026 · NCT06915025Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dubartoota · Haaromfame 01-Onk-2026 · NCT07851025A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Dubartoota · Haaromfame 29-Ful-2026 · NCT06890338Study of AVZO-021 in Patients With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT05867251A Study of Isoquercetin in People With Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07303894ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT05059444Whole Body Metabolic Activity as a Reflection of Tumor Metabolic Dysregulation and a Predictor of Treatment Response in Ovarian Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Dubartoota · Haaromfame 17-Hag-2026 · NCT07764133Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer
Namoota walitti qabaa jira
Umuriin 18 fi ol · Dubartoota · Haaromfame 06-Hag-2026 · NCT06386887AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dubartoota · Haaromfame 21-Ado-2026 · NCT07218809Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dubartoota · Haaromfame 02-Ado-2026 · NCT06819007A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
Namoota walitti qabaa jira
Umuriin 18 fi ol · Dubartoota · Haaromfame 01-Ado-2026 · NCT05429970[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 23-Wax-2026 · NCT07432633CT-95 in Advanced Cancers Associated With Mesothelin Expression
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Wax-2026 · NCT06756035Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Dubartoota · Haaromfame 19-Cam-2026 · NCT06305299Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Elb-2026 · NCT05297734A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Dubartoota · Haaromfame 07-Elb-2026 · NCT04516447A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Bit-2026 · NCT06395519A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Dubartoota · Haaromfame 03-Gur-2026 · NCT06469281CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Dubartoota · Haaromfame 23-Mud-2025 · NCT06690775Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 30 fi ol · Dubartoota · Haaromfame 16-Ful-2025 · NCT04794322A Study of NX-1607 in Adults With Advanced Malignancies
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2025 · NCT05107674Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Hag-2025 · NCT04429542A Beta-only IL-2 ImmunoTherapY Study
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ado-2025 · NCT05086692BP1001-A in Patients With Advanced or Recurrent Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Bit-2025 · NCT04196257Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 hanga 80 · Dubartoota · Haaromfame 28-Gur-2025 · NCT00005095Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.